MORGANTOWN, W.Va. – The West Virginia Clinical and Translational Science Institute has launched an innovative new service request tool; the iLab Core Management System. This new tool will allow WVCTSI members to access services faster while facilitating more effective and efficient service delivery and tracking.
iLab is a digital centralized system that creates a quick and user-friendly way to access all services offered by WVCTSI. Services that can be requested via iLab include: biostatistical and epidemiological consulting, West Virginia Practice-Based Research Network support, clinical trial support, study design, pilot grant submission, education and professional development assistance, and much more. Quarterly project update requests will now also be sent to all WVCTSI supported investigators and students via iLab.
“The most exciting thing about this new system is that it will streamline service delivery across WVCTSI programs and will capture and communicate investigator and project information in a way that ensures investigators do not overlook critical steps that could delay their research progress,” said Julie Lockman, Ph.D., director of investigator development with WVCTSI. “It will enable the entire service delivery process at WVCTSI to be as quick and efficient as possible.”
WVCTSI members at West Virginia University can access iLab using their WVU credentials. Members of the West Virginia Practice-Based Research Network and WVCTSI partner sites can find detailed registration instructions on the WVCTSI service request webpage.
General iLab inquiries can be directed to Emily Morgan at email@example.com or 304-293-6610. Additionally, users can also contact each core team through the “Contact Us” tab on individual core pages within iLab.
WVCTSI is funded by an IDeA Clinical and Translational grant from the National Institute of General Medical Sciences (2U54GM104942-02) to support the mission of building clinical and translational research infrastructure and capacity to impact health disparities in West Virginia.
West Virginia Clinical and Translational Science Institute
West Virginia University first site to launch clinical trial utilizing non-opioid micropellet implant for chronic pain
As part of an ongoing commitment to battle opioid addiction, the Rockefeller Neuroscience Institute (RNI) at West Virginia University today (Nov. 15) marked a major milestone, enrolling the first patient in a randomized clinical trial that will test the effectiveness of an injectable non-opioid, non-steroid micropellet to treat sciatica.
Assistant Professor Steve Davis recently spoke with the Milwaukee Journal Sentinel about needle exchange programs and the obstacles faced when trying to research their effectiveness. Davis is a faculty member in the WVU School of Public Health’s Department of Health Policy, Management, and Leadership.
WVU in the News: Innes' research looks to meditation and music in altering blood markers of Alzheimer’s disease
A research team led by Dr. Kim Innes, a professor in the West Virginia University School of Public Health, has found that a simple meditation or music listening program may alter certain biomarkers of cellular aging and Alzheimer’s Disease in older adults who are experiencing memory loss.